Galderma (GALD): Successful Injection in Swiss & Global Indices
Galderma is the only IPO addition to All World in Developed Europe for the September 2024 review which was announced on 23 August. It will be added...
371 Views
BWMX: 2Q Review: Managing Into the Positives; Reiterate Buy, $22.50 PT
We are reiterating our Buy rating and $22.50 price target and slightly raising our projections after Betterware registered below consensus 2Q24...
336 Views
BWMX: 2Q Preview: Another Quarter of Strong Proof; Reiterate Buy, $22.50 PT
We are reiterating our Buy rating, $22.50 price targe and projections for Betterware de Mexico with the company reporting 2Q24 (June) results...
207 Views
BWMX: 2H24 Signposts: Showing the Power of the Model; Reiterate Buy, $22.50 PT
We are reiterating our Buy rating, projections and $22.50 price target for Betterware de Mexico as we look ahead to key trends in 2H24 and...
138 Views
L’Occitane (973 HK): Conditional Offer Opens
The scrip option, an attractive offer and no vocal opposition should facilitate achieving the minimum acceptance condition. At the last close, the...
327 Views